Concetta Crivera

2.0k total citations
105 papers, 1.4k citations indexed

About

Concetta Crivera is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Concetta Crivera has authored 105 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 44 papers in Internal Medicine and 15 papers in Economics and Econometrics. Recurrent topics in Concetta Crivera's work include Venous Thromboembolism Diagnosis and Management (44 papers), Atrial Fibrillation Management and Outcomes (41 papers) and Acute Myocardial Infarction Research (16 papers). Concetta Crivera is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (44 papers), Atrial Fibrillation Management and Outcomes (41 papers) and Acute Myocardial Infarction Research (16 papers). Concetta Crivera collaborates with scholars based in United States, Canada and United Kingdom. Concetta Crivera's co-authors include Jeff Schein, Patrick Lefèbvre, François Laliberté, Winnie W. Nelson, Riad Dirani, Craig I Coleman, Jeffrey Schein, Colleen A. McHorney, Dejan Milentijevic and W. Frank Peacock and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Concetta Crivera

100 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Concetta Crivera United States 22 724 547 330 149 149 105 1.4k
Christel Castelli France 16 285 0.4× 116 0.2× 56 0.2× 218 1.5× 48 0.3× 43 1.0k
Steven Baroletti United States 15 233 0.3× 151 0.3× 45 0.1× 213 1.4× 116 0.8× 28 850
Michael Bullano United States 18 250 0.3× 161 0.3× 87 0.3× 277 1.9× 105 0.7× 37 882
PharmD United States 9 736 1.0× 509 0.9× 39 0.1× 158 1.1× 26 0.2× 150 1.5k
Marion Bertrand France 21 295 0.4× 82 0.1× 200 0.6× 317 2.1× 35 0.2× 51 1.4k
Onur Baser United States 15 148 0.2× 81 0.1× 62 0.2× 198 1.3× 85 0.6× 30 660
Suellen M. Curkendall United States 17 356 0.5× 26 0.0× 170 0.5× 81 0.5× 184 1.2× 32 1.5k
Lusine Abrahamyan Canada 19 299 0.4× 35 0.1× 46 0.1× 207 1.4× 110 0.7× 91 1.2k
RA Lawrenson United Kingdom 8 255 0.4× 308 0.6× 77 0.2× 82 0.6× 11 0.1× 13 895
Hiangkiat Tan United States 16 148 0.2× 52 0.1× 33 0.1× 242 1.6× 46 0.3× 62 1.2k

Countries citing papers authored by Concetta Crivera

Since Specialization
Citations

This map shows the geographic impact of Concetta Crivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Concetta Crivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Concetta Crivera more than expected).

Fields of papers citing papers by Concetta Crivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Concetta Crivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Concetta Crivera. The network helps show where Concetta Crivera may publish in the future.

Co-authorship network of co-authors of Concetta Crivera

This figure shows the co-authorship network connecting the top 25 collaborators of Concetta Crivera. A scholar is included among the top collaborators of Concetta Crivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Concetta Crivera. Concetta Crivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cherif, Honar, Qian Cai, Concetta Crivera, et al.. (2024). Overall Survival and Treatment Patterns Among Patients With Warm Autoimmune Hemolytic Anemia in Sweden: A Nationwide Population‐based Study. European Journal Of Haematology. 114(1). 129–138.
2.
Jagannath, Sundar, Concetta Crivera, Carolyn C. Jackson, et al.. (2023). Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma. Oncology and Therapy. 11(2). 263–275. 17 indexed citations
3.
Martin, Thomas, et al.. (2022). EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma. Value in Health. 25(7). S366–S366. 1 indexed citations
4.
5.
Peacock, W. Frank, Craig I Coleman, Philip S. Wells, et al.. (2019). Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care. Journal of health economics and outcomes research. 6(3). 160–173. 1 indexed citations
6.
Khorana, Alok A., Keith R. McCrae, Dejan Milentijevic, et al.. (2019). Duration of anticoagulant therapy and VTE recurrence in patients with cancer. Supportive Care in Cancer. 27(10). 3833–3840. 10 indexed citations
7.
Wang, Li, Onur Baser, Philip S. Wells, et al.. (2017). Overall Effectiveness of Rivaroxaban in Patients with Pulmonary Embolism. Clinical Therapeutics. 39(7). 1426–1436.e2. 2 indexed citations
8.
Wang, Li, Onur Başer, Philip S. Wells, et al.. (2016). Abstract 13112: Benefit of Early Discharge Among Patients With Low-risk Pulmonary Embolism: Focus on Net Clinical Impact. Circulation. 134(suppl_1). 1 indexed citations
9.
Coleman, C. Norman, et al.. (2016). Outcomes related to variation in hospital pulmonary embolus observation stay utilization. Value in Health. 19(3). A56–A56. 1 indexed citations
10.
Coleman, Craig I, Erin R. Weeda, W. Frank Peacock, et al.. (2016). IS RIVAROXABAN ASSOCIATED WITH SHORTER INPATIENT STAYS AND LOWER HOSPITAL COSTS VERSUS HEPARIN/WARFARIN IN LOW-RISK PULMONARY EMBOLISM PATIENTS?. Journal of the American College of Cardiology. 67(13). 2079–2079. 1 indexed citations
11.
Weeda, Erin R., W. Frank Peacock, Gregory J. Fermann, et al.. (2016). Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism. Journal of Thrombosis and Thrombolysis. 42(4). 513–519. 5 indexed citations
12.
McHorney, Colleen A., Concetta Crivera, François Laliberté, et al.. (2015). Abstract 13611: Adherence to Non-VKA Oral Anticoagulant Medications Based on the Pharmacy Quality Alliance Measure. Circulation. 132(suppl_3). 1 indexed citations
13.
Coleman, Craig I, Christine G. Kohn, Concetta Crivera, Jeffrey Schein, & W. Frank Peacock. (2015). Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database. BMJ Open. 5(10). e009251–e009251. 13 indexed citations
14.
Laliberté, François, Michel Cloutier, Concetta Crivera, et al.. (2015). Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users. Advances in Therapy. 32(3). 216–227. 25 indexed citations
15.
Chen, Shih‐Yin, Concetta Crivera, Michael B. Stokes, Luke Boulanger, & Jeff Schein. (2014). Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome. BMC Health Services Research. 14(1). 80–80. 12 indexed citations
16.
Chen, Shih‐Yin, et al.. (2013). Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population. ClinicoEconomics and Outcomes Research. 5. 181–181. 15 indexed citations
17.
Stephenson, Judith J., et al.. (2012). Adherence to oral second‐generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims. International Journal of Clinical Practice. 66(6). 565–573. 50 indexed citations
18.
Macfadden, Wayne, Cherilyn DeSouza, Concetta Crivera, et al.. (2011). Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results. BMC Psychiatry. 11(1). 167–167. 27 indexed citations
19.
20.
Crivera, Concetta, Dong‐Churl Suh, Edmund Huang, et al.. (2006). The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients. Current Medical Research and Opinion. 22(11). 2301–2311. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christel Castelli Breakdown of academic impact, for papers by Steven Baroletti Breakdown of academic impact, for papers by Michael Bullano Breakdown of academic impact, for papers by PharmD Breakdown of academic impact, for papers by Marion Bertrand Breakdown of academic impact, for papers by Onur Baser Breakdown of academic impact, for papers by Suellen M. Curkendall Breakdown of academic impact, for papers by Lusine Abrahamyan Breakdown of academic impact, for papers by RA Lawrenson Breakdown of academic impact, for papers by Hiangkiat Tan
Rankless by CCL
2026